2021 Definitive Additional Soliciting Materials
2021 Annual Meeting Notice and Proxy Statement
| Date: | Tuesday, June 15, 2021 |
| Time: | 10:00 a.m., local time |
| Place: | Hilton Garden Inn |
| 14975 Shady Grove Road | |
| Rockville, MD 20850 |
CASI is a U.S. NASDAQ-listed biopharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innovative therapeutics in China, the U.S., and throughout the world. We have offices in Rockville, Maryland, and a wholly owned subsidiary in Beijing, China, through which substantially all of our operations are conducted.
EVOMELA® (melphalan) for Injection, ZEVALIN® (ibritumomab tiuxetan), and MARQIBO® (vincristine sulfate LIPOSOME injection) are proprietary to Acrotech Biopharma LLC and its affiliates.
© 2020 CASI Pharmaceuticals Inc.
All Rights Reserved.
